Day One Biopharmaceuticals, Inc.
SEC CIK 1845337 · DAWN · last insider filing 2026-04-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Garland J. Scott | Director | filed 2021 - 2026 |
| Ramasastry Saira | Director | filed 2021 - 2026 |
| Holles Natalie C. | Director | filed 2021 - 2026 |
| Nicholson Garry A | Director | filed 2022 - 2026 |
| Dable Habib J | Director | filed 2024 - 2026 |
| Grossman William | Director | filed 2024 - 2026 |
| Josey John A. | Director | filed 2021 - 2026 |
| Bender Jeremy | Director · Chief Executive Officer | filed 2021 - 2026 |
| Gladstone Michael | Director | filed 2021 - 2024 |
| Becker Daniel J. | Director | filed 2021 - 2023 |
| Papanek Julie | Director | filed 2021 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| York Charles N II | COO, CFO and Secretary | filed 2021 - 2026 |
| Vasconcelles Michael | Head of Research and Dev. | filed 2025 - 2026 |
| Dubow Adam | General Counsel | filed 2023 - 2026 |
| Merendino Lauren | Chief Commercial Officer | filed 2025 - 2026 |
| Blackman Samuel C. | Head of Research and Developme | filed 2021 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.